Clinical Trials · NCT01218581

Aromatase Inhibitors or GnRH-a for Uterine Adenomyosis

CompletedPhase 2/Phase 3Gonadorelin (Approved)
Phase
Phase 2/Phase 3
Recruitment status
Completed
Sponsor
Mansoura University
Enrollment
32
Start date
Dec 2005
Locations
1 site, Egypt
Primary endpoint
Study in the Efficacy of Aromatase Inhibitor vs. Gonadotrpins Releasing Hormone Agonists in Treating Premenopausal Women With Uterine Adenomyosis
View Gonadorelin compound reference